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a b s t r a c t
The infl ammatory processes in the joints of a child with juvenile idiopathic arthritis (JIA) 
can persist into adulthood. Infl ammation has been linked to distortions of the lipid pro-
fi le and accelerated atherogenesis. In the present study, we examined the lipid profi les 
of adults with JIA compared with those of healthy people. A lipid profi le of a sample of 
54 adults with JIA (57.3% with polyarticular JIA, 37.0% with oligoarticular JIA, 1.9% with 
enthesitis-related JIA and 3.7% with systemic onset JIA) and 54 healthy subjects were com-
pared. In the adults with JIA, data on gender, age, age at disease onset, the presence of 
rheumatoid factor (RF) and antinuclear antibodies (ANA), a Health Assessment Question-
naire (HAQ) and the disease duration were collected. We found that hypercholesterolaemia, 
increased low-density lipoprotein (LDL) and decreased high-density lipoprotein (HDL) were 
more common in patients with JIA than the controls (P = 0.016, P < 0.0001 and P = 0.0008, 
respectively). Changes in the levels of total cholesterol (TC) and LDL were more common in 
the individuals who had a later onset of disease (P = 0.0017 for TC and P = 0.023 for LDL). In 
the entire JIA group, no other variable, such as RF, ANA, disease duration or responses to the 
HAQ, could be linked to dyslipidaemia (P = non-signifi cant). We concluded that the adult 
patients with JIA have a lipid profi le with increased TC and LDL levels and decreased levels 
of HDL compared to the controls. No clinical feature could be correlated with this change 
except for the age at disease onset.
© 2013 Elsevier Editora Ltda. All rights reserved.
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r e s u m o
O processo infl amatório articular de uma criança com artrite idiopática juvenil (AIJ) pode 
persistir na vida adulta. A infl amação tem sido ligada a distorções do perfi l lipídico e à ate-
rogênese acelerada. Neste trabalho, estudou-se o perfi l lipídico de indivíduos adultos com 
AIJ, comparando-o ao de pessoas saudáveis. Foram recrutados 54 adultos com AIJ (57,3% 
poliarticular, 37% oligoarticular, 1,9% do subtipo entesítica e 3,7% do subtipo sistêmica) e 54 
indivíduos saudáveis para comparação de perfi l lipídico. Nos adultos AIJ, coletaram-se da-
dos sobre sexo, idade e idade de início da doença, presença de fator reumatoide (FR) e fator 
antinuclear (FAN), HAQ (Health Assessment Questionnaire) e tempo de doença. Observou-se 
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que hipercolesterolemia, aumento de LDL e diminuição de HDL foram mais comuns em 
pacientes com AIJ do que nos controles (com P = 0,016; P < 0,0001 e P = 0,0008, respecti-
vamente). Alterações no colesterol total (CT) e no LDL foram mais comuns em indivíduos 
com início de doença mais tardio (P = 0,0017 para CT e P = 0,023 para LDL). Em todo o gru-
po de pacientes com AIJ nenhuma outra variável pode ser ligada à dislipidemia tal como 
presença de FR, FAN, duração de doença e HAQ (P = ns). Concluiu-se que pacientes adultos 
com AIJ apresentam um perfi l lipídico com aumento de CT e de LDL, e diminuição de HDL 
em relação aos controles. Nenhuma característica clínica pode ser ligada a essa alteração, 
exceto idade de início da doença.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Juvenile idiopathic arthritis (JIA) is the most common arthrop-
athy in childhood, and this disease involves several subtypes 
of arthritis that appear before 16 years.1 In affected children, 
JIA has the potential to cause serious impacts on performance 
in adulthood. Nevertheless, there are few studies on adults 
who developed JIA.
It is a well-known fact that the survival of individuals sub-
ject to long-term infl ammation is altered by the risk of acceler-
ated atherogenesis.2,3 There are many studies on rheumatoid 
arthritis (RA) in adults that clearly demonstrate this effect, 
which causes an increased risk of death from cardiovascular 
complications.4-7 Changes in the lipid profi le due to exposure 
to pro-infl ammatory cytokines, such as interleukin (IL)-1β, IL-6 
and tumour necrosis factor-α (TNF-α), are among the causes as-
sociated with the increased risk of atherogenesis.7 The chronic 
use of glucocorticoids for the treatment of this condition has 
been associated with hypercholesterolaemia.8 In patients with 
RA, decreased high-density lipoprotein (HDL)-cholesterol lev-
els have been found, as well as less statistically signifi cant 
changes in total cholesterol (TC) and low-density lipoprotein 
(LDL)-cholesterol levels and a change in the relationship be-
tween the different components of the lipid profi le.9 
JIA is a disease with a much more heterogeneous clini-
cal profi le than RA, and manifestations with infl ammatory 
processes of different intensity are also expected.1 A study 
that compared 25 children with JIA with 15 healthy children 
revealed increased levels of TC and LDL-cholesterol and a 
decreased level of HDL-cholesterol.10 Another study demon-
strated the presence of increased triglycerides (TG) and de-
creased HDL-cholesterol levels, and this study also indicated 
that these changes were proportional to the duration of the 
disease and the level of infl ammatory activity.11 
The present study evaluated the lipid profi les of adult pa-
tients with JIA, compared these profi les with the lipid profi le 
of a healthy population and established the relationship of 
the lipid profi les to the clinical variables of JIA.
Method
The present study was an analytical cross-sectional study of 
the lipid profi les of adult patients with JIA that was duly ap-
proved by the local research ethics committee. All the partici-
pants signed an informed consent form. This sample consists 
of all the adult patients with JIA treated at the outpatient rheu-
matology clinic of a university hospital in the last fi ve years 
who agreed to participate in the study. The participants were 
classifi ed according to the different JIA subtypes described by 
the International League of Associations for Rheumatology 
(ILAR)1, and the following data were collected: the demographic 
data, the autoantibodies profi le (antinuclear antibodies, ANA 
and IgM rheumatoid factor, RF), the Health Assessment Ques-
tionnaire (HAQ)12 values and the drugs being used. Pregnant 
and nursing women, as well as individuals with uncorrected 
hypothyroidism (n = 3), were excluded from the study.
For comparison, subjects without an infl ammatory process, 
who were paired according to age and sex and who sought pre-
ventive care at the gynaecology outpatient clinic or refraction 
correction at the ophthalmology service, were studied.
The levels of TC, TG and LDL- and HDL-cholesterol were 
obtained from the population of adults with JIA and from the 
controls using the enzymatic colorimetric method. The fol-
lowing values were considered normal: TC values up to 200 
mg/dL, HDL-cholesterol levels above 40 mg/dL, LDL-cholester-
ol levels up to 110 mg/dL and TG levels up to 150 mg/dL.13
The data obtained were analysed with frequency and con-
tingency tables. For the comparative analysis of the nominal 
data, the Fisher’s test and the chi-square test were used. Ac-
cording to the sample distribution, the Student’s t-test and 
the Mann-Whitney test were used to study the numerical val-
ues. The Spearman test was used for the correlation studies. 
A signifi cance level of 5% was specifi ed. 
Results
Characterisation of the sample studied 
Of the 54 individuals of the control group, 40 (74.1%) were 
women and 14 (25.9%) were men, with a mean age of 20.6 ± 1.8 
years; the mean body mass index (BMI) was 22.6 ± 3.5. None 
of the subjects were smokers. There were no cases of diabe-
tes mellitus or hypertension. In the group of adults with JIA, 
there were 54 patients, and 72.2% (39/54) of the JIA patients 
were women and 27.8% (15/54) were men (P = 0.8 compared to 
the control group), with a mean age of 22.0 ± 5.2 years (P = 0.1 
compared to the control group); the mean disease time was 
15.0 ± 7.8 years, and the mean age at diagnosis was 9.4 ± 4.1 
years. The mean BMI was 23.4 ± 4.0 (P = 0.3 compared to the 
control group). Among these 54 patients, 3 were smokers (P = 
0.2 compared to the control group). Among the patients with 
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JIA, 1 had hypertension and 1 had diabetes mellitus (P = 1.0 for 
both variables compared to the control group).
The systemic subgroup of JIA was present in 2/54 (3.7%) 
of the patients; 1/54 JIA patients (1.8%) had the enthesitis-
related subtype, 20/54 (37.0%) had the oligoarticular subtype, 
and 31/54 (57.4%) had the polyarticular subtype. Among the 
JIA patients, 28.0% tested positive for ANA, and 18.0% were 
positive for RF. There was a history of uveitis in 13.0% of the 
patients with JIA. Approximately 6.0% of the patients used 
sulfasalazine; 10.0% used lefl unomide; 31.3% used chloro-
quine; 33.3% used anti TNF-α; 33.3% used prednisone (at a 
mean dose of 9.5 mg/day); and 50.9% used methotrexate. The 
HAQ had a median value of 0.3.
Lipid profi le study
The following values were altered in the population of adults 
with JIA: TC, in 16.6% of the adult JIA patients; HDL-choles-
terol, in 23% of the patients; LDL-cholesterol, in 20.3% of 
the JIA group; and TG, in 16.6% of this group. In the control 
sample, the following values were altered: TC, in 3.7% of the 
control patients; HDL-cholesterol in 1.8% of the controls; LDL-
cholesterol in 1.8% of the control group; and TG, in 18.5% of 
this group. A comparison between the two populations can 
be seen in Fig. 1.
The mean values obtained for TC, HDL-cholesterol and TG 
in the 2 groups are presented in Table 1, in which higher lev-
els of LDL-cholesterol and TC can be observed in the group of 
adults with JIA and higher levels of HDL-cholesterol and TG 
can be observed in the control group.
When studying the lipid profi les of the adult patients with 
JIA according to the subtype at the onset, there were no dif-
ferences between the oligoarticular and the polyarticular sub-
types (Table 2).
The analysis of the association between the lipid profi les 
and the presence of RF (RF and TC, P = 0.7; RF and HDL, P = 0.3; 
RF and LDL, P = 0.5; and RF and TG, P = 0.3) or the presence of 
ANA (ANA and TC, P = 0.8; ANA and HDL, P = 0.8; ANA and LDL, 
P = 0.6; and ANA and TG, P = 0.7) indicated that the association 
was not signifi cant. The same was observed for the correla-
tion between the lipid profi les and the length of time of the 
disease (TC with P = 0.1 and Spearman’s R = 0.19; HDL with P = 
0.1 and Spearman’s R = 0.19; LDL with P = 0.2 and Spearman’s 
R = 0.15; and TG with P = 0.6 and Spearman’s R = −0.06). 
The analysis of the correlation between the HAQ values 
and the lipid profi les did not reveal any positive correlation 
(HAQ and CT, P = 0.1 and Spearman’s R = 0.20; HAQ and HDL, 
P = 0.1 and Spearman’s R = 0.20; HAQ and LDL, P = 0.6 and 
Spearman’s R = 0.05; and HAQ and TG, P = 0.9 and Spearman’s 
R = −0.01). However, the correlation between the age at the 
onset of the disease and the level of TC was positive [P = 0.001; 
Spearman’s R = 0.4; 95% Confi dence Interval (CI), 0.1 to 0.6], as 
was the correlation between the age at disease onset and LDL 
(P = 0.02; Spearman’s R = 0.3; 95% CI, 0.03 to 0.54), while there 
was no association of this parameter with HDL (P = 0.3; Spear-
man’s R = 0.1) or TG (P = 0.2; Spearman’s R = 0.1).
Finally, when comparing the lipid profi les of the patients 
who were using corticoids (n = 18/54) to those of the patients 
not using corticoids, we found the following: for the patients 
using and not using corticoids, the mean values for choles-
terol were 173.0 mg/dL and 169.0 mg/dL (P = 0.2); the mean 
values for LDL-cholesterol were 102.8 mg/dL and 100.6 mg/dL 
(P = 0.2); the mean values for HDL-cholesterol were 52.1 mg/dL 
and 44.5 mg/dL (P = 0.03); and the levels of TG were 95.0 mg/dL 
and 96.5 mg/dL (P = 0.3), respectively.
Discussion 
A few results stand out from the data of the present study. 
The fi rst is, undoubtedly, the changes found in the lipid pro-
fi les of the adult individuals with JIA, which displayed pro-
Table 1 – Lipid profi les of adult patients with juvenile 
idiopathic arthritis compared to those of the control group
Adults with JIA 
N = 54
Control 
N = 54
P
Cholesterol 
(mg/dL)
102.0-288.0 
Median = 170.0
109.0-213.0 
Median = 143.5
0.0004
HDL (mg/dL) 20.1-79.0 
Median = 45.0
39.0-69.0 
Median = 55.0
< 0.0001
LDL (mg/dL) 40.6-192.4 
Median = 100.6
31.0-114.0 
Median = 54.5
< 0.0001
Triglycerides 
(mg/dL)
44.0-311.0 
Median = 96.5
104.0-230.0 
Median = 131.5
< 0.0001
JIA, juvenile idiopathic arthritis.
Table 2 – Comparison of the lipid profi le of adult 
patients with juvenile idiopathic arthritis of the 
oligoarticular and the polyarticular subtypes 
Polyarticular 
N = 31
Oligoarticular 
N = 20
P
Cholesterol 
(mg/dL)
105.0-282.0 
Median = 166.0
117.5-288.0 
Median = 171.5
0.3
HDL (mg/dL) 29.0-69.0 
Median = 47.0
20.1-79.0 
Median = 42.5
0.3
LDL (mg/dL) 40.6-166.0 
Median = 95.2
58.5-192.4 
Median = 111.8
0.06
Triglycerides 
(mg/dL)
45.0-311.0 
Median = 97.0
44.0-179.0 
Median = 91.0
0.5
Fig. 1 – Frequency (%) of abnormal values in the lipid 
profi les of adult individuals with JIA and the control group
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atherogenic characteristics. We observed increases in the TC 
and LDL-cholesterol levels as well as decreases in the HDL-
cholesterol levels in the JIA group compared to the control 
group. None of the characteristics of the JIA, such as the sub-
type of the disease or the presence of autoantibodies, identi-
fi ed a group with a higher risk for these changes, although the 
patients with a late onset of the disease had higher values of 
TC and LDL-cholesterol. 
A study by Gonçalves et al.14 conducted with 51 children with 
JIA (mean age of 11 years) also found decreased HDL, but, unlike 
the present study, these authors also found increased TG. In our 
study, the prevalence of hypertriglyceridaemia was the same in 
the 2 groups; however, the mean level of TG was higher in the 
control group. Bakkaloglu et al.,15 in a study of 19 Turkish chil-
dren with JIA, did not fi nd increased TG in the sample. 
In the present study, the patients with the oligoarticular 
subtype of JIA had a tendency to have increased LDL levels. 
This aspect is interesting because the patients with the poly-
articular subtype, i.e., with more intense infl ammation, would 
be expected to be more affected. However, all of these patients 
were being treated, and thus, the intensity of the infl amma-
tory process may have been equalised by the use of disease 
modifying drugs.
The use of corticoids is another interesting aspect. In the 
present sample, the levels of HDL-cholesterol were higher in 
the patients that were using corticoids. The effect of gluco-
corticoids on the lipid profi les of rheumatoid patients may be 
considered to be ambiguous, at best. While, on the one hand, 
the direct effect of these agents on lipid metabolism suggests 
that glucocorticoids are pro-atherogenic,8 on the other hand, 
the anti-infl ammatory effects of these corticoids must also be 
considered.16 The anti-infl ammatory action of the corticoids 
may counteract the lipid changes caused by the infl amma-
tion, thus resulting in a more benign lipid profi le. Boers et 
al.16 demonstrated that, in individuals with RA, the dyslipi-
daemia caused by the activity of the disease was reversed by 
a treatment that included glucocorticoids. Unfortunately, in 
the present study, there were no data on the previous use of 
corticoids, which would have allowed for a study of the ef-
fects of cumulative doses of these drugs. Many of the patients 
analysed herein came from different paediatric clinics, which 
made it diffi cult to obtain data on previous treatments. 
Another fact that stands out is the existence of lipid ab-
normalities in a very young population (mean age of 25 years). 
This last observation is very important when considering 
the risks of cardiovascular disease and its high morbidity 
and mortality. The life expectancy in patients with JIA is de-
creased. French et al.17 found a mortality rate 4 times higher in 
this population compared to the general population. Thomas 
et al.18, in a study of the standardized mortality ratio (SMR) in 
JIA, found an increase of 3-fold for men and 5-fold for women, 
values that were  found to be higher than those obtained for 
early RA in the adult. However, the reasons for this high mor-
tality are not well known.18,19
Finally, we conclude that adult patients with JIA have an 
increased risk of dyslipidaemia and that all efforts towards 
controlling this dyslipidaemia should be undertaken.
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